Health-related quality of life before and after a breast cancer diagnosis

被引:0
作者
Amy Trentham-Dietz
Brian L. Sprague
Ronald Klein
Barbara E. K. Klein
Karen J. Cruickshanks
Dennis G. Fryback
John M. Hampton
机构
[1] University of Wisconsin,Department of Population Health Sciences
[2] University of Wisconsin Paul P. Carbone Comprehensive Cancer Center,Department of Ophthalmology and Visual Sciences
[3] University of Wisconsin,Department of Industrial Engineering
[4] University of Wisconsin,undefined
来源
Breast Cancer Research and Treatment | 2008年 / 109卷
关键词
Breast cancer; Epidemiology; Functional health status; Long-term cancer survivors; Prospective; Quality of life; SF-36;
D O I
暂无
中图分类号
学科分类号
摘要
While many reports describe health-related quality of life (QOL) among breast cancer survivors, few compare QOL before and after diagnosis and whether changes in QOL substantially differ from changes experienced by all women during aging. QOL was examined in a cohort of female residents of Beaver Dam, Wisconsin, aged 43–86 years at the time of a 1988–1990 baseline examination (N = 2,762; 83% of eligible). Participants were re-contacted four times through 2002 to ascertain QOL using the 36-item Short Form Health Survey (SF-36). QOL data for 114 incident breast cancer cases identified by data linkage with the statewide cancer registry were compared with data for 2,527 women without breast cancer. Women with breast cancer averaged 4.5 (95% CI: 1.6, 7.3) points lower than control women on the SF-36 Physical Component Summary (PCS) scale, regardless of time since diagnosis (up to 13 years). Women with breast cancer also reported lower scores on the SF-36 Mental Component Summary (MCS) scale within two years after diagnosis, but not at more distant times. In longitudinal analyses, 26 women who completed the SF-36 before and after breast cancer diagnosis experienced larger declines than age-matched controls in seven of the eight SF-36 health domains (all but role-emotional) and reported relative declines of −7.0 (95% CI: −11.5, −2.6) and −2.9 (95% CI: −6.3, 0.6) on the PCS and MCS scales, respectively. These results suggest that breast cancer survivors experience relative declines in health-related QOL across a broad spectrum of domains, even many years after diagnosis.
引用
收藏
页码:379 / 387
页数:8
相关论文
共 94 条
[1]  
Brenner H(2002)Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis Lancet 360 1131-1135
[2]  
Goodwin PJ(2003)Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock J Natl Cancer Inst 95 263-281
[3]  
Black JT(2002)The impact of hormonal treatments on quality of life of patients with metastatic breast cancer Clin Ther 24 C26-42
[4]  
Bordeleau LJ(2006)Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial JAMA 295 2742-2751
[5]  
Costantino J(2006)Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer N Engl J Med 355 1851-1862
[6]  
Land SR(2005)Adjuvant docetaxel for node-positive breast cancer N Engl J Med 352 2302-2313
[7]  
Wickerham DL(2000)Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy Ann Surg 231 883-889
[8]  
Costantino JP(2003)Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want? Health Qual Life Outcomes 1 45-2619
[9]  
Poole CJ(2005)Quality of life among long-term breast cancer survivors: a systematic review Eur J Cancer 41 2613-882
[10]  
Earl HM(1995)Analysis of the factors influencing the quality of life of patients with advanced or recurrent breast cancer Surg Today 25 874-718